| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |